Skip to main content
logo
Kezar Life Sciences, Inc. (KZR)
May 11, 2026 - KZR was delisted (reason: acquired by AUPH)
7.29
0.00 (0.00%)
Inactive · Last trade price on May 8, 2026

Kezar Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
5446496894,8229,407
Market Cap Growth
55.19%-6.04%-92.88%-85.71%-48.74%288.71%
Enterprise Value
-11.02-25.76-70.51503.774,5649,211
Last Close Price
7.296.296.7294.70704.001672.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---98.46--
PB Ratio
0.820.660.423.6717.8747.78

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---71.97--
EV/EBITDA Ratio
-0.440.79---
EV/EBIT Ratio
-0.440.78---
EV/FCF Ratio
-0.500.95---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-00.110.080.070.07
Net Debt / Equity Ratio
-0.99-0.99-0.99-0.97-0.95-0.99
Net Debt / EBITDA Ratio
1.351.201.301.653.643.66
Net Debt / FCF Ratio
1.541.341.562.194.224.55
Asset Turnover
-000.0300
Quick Ratio
23.9810.936.5111.3525.1525.37
Current Ratio
24.4611.526.7611.6625.9825.77
Return on Equity (ROE)
-67.12%-59.93%-55.00%-44.54%-29.24%-32.34%
Return on Assets (ROA)
-67.53%-53.41%-49.52%-42.79%-27.50%-29.56%
Return on Invested Capital (ROIC)
-11063.00%-8616.18%-3029.25%-1130.86%-830.36%-1273.95%
Return on Capital Employed (ROCE)
-72.19%-60.80%-55.27%-45.29%-28.56%-30.78%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-0.41%-0.37%-0.48%-7.70%-27.69%-19.90%
Total Shareholder Return
-0.41%-0.37%-0.48%-7.70%-27.69%-19.90%
SEC Filings: 10-K · 10-Q